Blood Pressure Assessment in Atrial Fibrillation
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01088269 |
Recruitment Status
:
Recruiting
First Posted
: March 17, 2010
Last Update Posted
: September 14, 2017
|
Sponsor:
University of Athens
Information provided by (Responsible Party):
George S. Stergiou, University of Athens
Tracking Information | |||||
---|---|---|---|---|---|
First Submitted Date | March 16, 2010 | ||||
First Posted Date | March 17, 2010 | ||||
Last Update Posted Date | September 14, 2017 | ||||
Study Start Date | March 2010 | ||||
Estimated Primary Completion Date | December 2017 (Final data collection date for primary outcome measure) | ||||
Current Primary Outcome Measures |
Blood Pressure Measurement in Atrial Fibrillation,Serum Markers and echocardiographic indexes in atrial fibrillation (AF) [ Time Frame: Baseline ]
|
||||
Original Primary Outcome Measures |
Blood Pressure Measurement in Atrial Fibrillation,Serum Markers and echocardiographic indexes in AF [ Time Frame: Baseline ]
|
||||
Change History | Complete list of historical versions of study NCT01088269 on ClinicalTrials.gov Archive Site | ||||
Current Secondary Outcome Measures | Not Provided | ||||
Original Secondary Outcome Measures | Not Provided | ||||
Current Other Outcome Measures | Not Provided | ||||
Original Other Outcome Measures | Not Provided | ||||
Descriptive Information | |||||
Brief Title | Blood Pressure Assessment in Atrial Fibrillation | ||||
Official Title | Evaluation of the Oscillometric Blood Pressure Measurement in Atrial Fibrillation and Relation of Blood Pressure With Serum Biomarkers and Echocardiographic Indexes | ||||
Brief Summary | This is a cross-sectional study including patients with permanent atrial fibrillation. Assessment will include:
|
||||
Detailed Description | Not Provided | ||||
Study Type | Observational | ||||
Study Design | Observational Model: Case-Control Time Perspective: Cross-Sectional |
||||
Target Follow-Up Duration | Not Provided | ||||
Biospecimen | Not Provided | ||||
Sampling Method | Non-Probability Sample | ||||
Study Population | SUBJECTS REFERRED TO HYPERTENSION CENTER | ||||
Condition | Atrial Fibrillation | ||||
Intervention | Not Provided | ||||
Study Groups/Cohorts |
|
||||
Publications * | Not Provided | ||||
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. |
|||||
Recruitment Information | |||||
Recruitment Status | Recruiting | ||||
Estimated Enrollment |
100 | ||||
Original Estimated Enrollment |
70 | ||||
Estimated Study Completion Date | December 2017 | ||||
Estimated Primary Completion Date | December 2017 (Final data collection date for primary outcome measure) | ||||
Eligibility Criteria | Inclusion Criteria:
Exclusion Criteria:
|
||||
Sex/Gender |
|
||||
Ages | 25 Years to 85 Years (Adult, Senior) | ||||
Accepts Healthy Volunteers | No | ||||
Contacts |
|
||||
Listed Location Countries | Greece | ||||
Removed Location Countries | |||||
Administrative Information | |||||
NCT Number | NCT01088269 | ||||
Other Study ID Numbers | BPM IN AF | ||||
Has Data Monitoring Committee | No | ||||
U.S. FDA-regulated Product | Not Provided | ||||
IPD Sharing Statement | Not Provided | ||||
Responsible Party | George S. Stergiou, University of Athens | ||||
Study Sponsor | University of Athens | ||||
Collaborators | Not Provided | ||||
Investigators |
|
||||
PRS Account | University of Athens | ||||
Verification Date | September 2017 |